Cancer as a disease of tissue pattern formation

Progress in Histochemistry and Cytochemistry

Volumn 47, Issue 3, 2012, Pages 175-207

  Marongiu, Fabio ^a   Doratiotto, Silvia ^a   Sini, Marcella ^a   Serra, Maria Paola ^a   Laconi, Ezio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ADENOCARCINOMA; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CARCINOMA; CELL AGING; CELL GROWTH; CELL HYPOXIA; CELL POLARITY; CELL POPULATION; CELL PROLIFERATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DYSPLASIA; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER NODULE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METAPLASIA; MORPHOGENESIS; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRECANCER; TISSUE STRUCTURE; TUMOR MICROENVIRONMENT;

ANOXIA; HUMANS; MORPHOGENESIS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84866916191     PISSN: 00796336     EISSN: 18732186     Source Type: Journal    
DOI: 10.1016/j.proghi.2012.08.001     Document Type: Article

References (193)

1. Aichler M., Seiler C., Tost M., Siveke J., Mazur P.K., Da Silva-Buttkus P., Bartsch D.K., Langer P., Chiblak S., Dürr A., Höfler H., Klöppel G., Müller-Decker K., Brielmeier M., Esposito I. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J Pathol 2012, 226(5):723-734.
2. Aranda V., Haire T., Nolan M.E., Calarco J.P., Rosenberg A.Z., Fawcett J.P., Pawson T., Muthuswamy S.K. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nature Cell Biol 2006, 8:1235-1245.
3. Auerbach O., Hammond E., Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 1979, 300:381-386.
4. Baena-Lopez L.A., Nojima H., Vincent J.P. Integration of morphogen signalling within the growth regulatory network. Curr Opin Cell Biol 2012, 24(2):166-172.
5. Barakat R.R., Federici M.G., Saigo P.E., Robson M.E., Offit K., Boyd J. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer 2000, 89(2):383-390.
6. Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev 2004, 18:1909-1925.
7. Bindra R.S., Glazer P.M. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res 2005, 569(1-2):75-85.
8. Bindra R.S., Schaffer P.J., Meng A., Woo J., Måseide K., Roth M.E., Lizardi P., Hedley D.W., Bristow R.G., Glazer P.M. Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability. Ann N Y Acad Sci. 2005, 1059:184-195.
9. Bodian C.A., Perzin K.H., Lattes R., Hoffmann P., Abernathy T.G. Prognostic significance of benign proliferative breast disease. Cancer 1993, 71(12):3896-3907.
10. Boccaccio C., Comoglio P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006, 6(8):637-645.
11. Boggiano J.C., Fehon R.G. Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell. 2012, 22(4):695-702.
12. Bonne C., Hartz P.H., Klerks J.V., Posthuma J.H., Radsma W., Tjokronegoro S. Morphology of the stomach and gastric secretion in Malays and Chinese and the different incidence of gastric ulcer and gastric cancer in these races. Am J Cancer 1938, 33:265-269.
13. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dörken B., Jenuwein T., Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005, 436(7051):660-665.
14. Bray K., Brakebusch C., Vargo-Gogola T. The Rho GTPase Cdc42 is required for primary mammary epithelial cell morphogenesis in vitro. Small Gtpases 2011, 2(5):247-258.
15. Brenner H., Haug U., Arndt V., Stegmaier C., Altenhofen L., Hoffmeister M. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 2010, 138:870-876.
16. Bretthauer M., Kalager M. Colonoscopy as a triage screening test. N Engl J Med 2012, 366(8):759-760.
17. Breuer R.H., Pasic A., Smit E.F., van Vliet E., Vonk Noordegraaf A., Risse E.J., Postmus P.E., Sutedja T.G. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res. 2005, 11(2 Pt 1):537-543.
18. Bristow R.G., Hill R.P. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008, 8:180-192.
19. Calzada M.J., Esteban M.A., Feijoo-Cuaresma M., Castellanos M.C., Naranjo-Suárez S., Temes E., Méndez F., Yánez-Mo M., Ohh M., Landázuri M.O. Von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. Cancer Res 2006, 66(3):1553-1560.
20. Campisi J. Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev 2011, 21(1):107-112.
21. Caro I., Low J.A. The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment. Clin Cancer Res 2010, 16(13):3335-3339.
22. Casey M.J., Bewtra C., Hoehne L.L., Tatpati A.D., Lynch H.T., Watson P. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Gynecol Oncol. 2000, 78(3 Pt 1):278-287.
23. Chan N., Koritzinsky M., Zhao H., Bindra R., Glazer P.M., Powell S., Belmaaza A., Wouters B., Bristow R.G. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res 2008, 68:605-612.
24. Chen C.L., Chu J.S., Su W.C., Huang S.C., Lee W.Y. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch 2010, 457(1):53-61.
25. Chen C.L., Schroeder M.C., Kango-Singh M., Tao C., Halder G. Tumor suppression by cell competition through regulation of the Hippo pathway. Proc Natl Acad Sci USA 2012, 109(2):484-489.
26. Chiche J., Ilc K., Laferrière J., Trottier E., Dayan F., Mazure N.M., Brahimi-Horn M.C., Pouysségur J Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009, 69(1):358-368.
27. Clark-Knowles K.V., Garson K., Jonkers J., Vanderhyden B.C. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Exp Cell Res. 2007, 313(1):133-145.
28. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguría A., Zaballos A., Flores J.M., Barbacid M., Beach D., Serrano M. Tumour biology: senescence in premalignant tumours. Nature 2005, 436(7051):642.
29. Colletti M., Cicchini C., Conigliaro A., Santangelo L., Alonzi T., Pasquini E., Tripodi M., Amicone L. Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology 2009, 137(2):660-672.
30. Cooke V.G., LeBleu V.S., Keskin D., Khan Z., O'Connell J.T., Teng Y., Duncan M.B., Xie L., Maeda G., Vong S., Sugimoto H., Rocha R.M., Damascena A., Brentani R.R., Kalluri R. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012, 21(1):66-81.
31. Correa P., Cuello C., Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst 1970, 44:297-306.
32. Correa P., Haenszel W., Cuello C., Tannenbaum S., Archer M. A model for gastric cancer epidemiology. Lancet 1975, 2:58-60.
33. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 1992, 52:6735-6740.
34. Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis 2012, 13(1):2-9.
35. Debnath J., Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005, 5(9):675-688.
36. Degregori J. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?. Oncogene 2012 Jul 2, (Epub).
37. Demidenko Z.N., Blagosklonny M.V. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008, 7:3355-3361.
38. Doratiotto S., Marongiu F., Faedda S., Pani P., Laconi E. Altered growth pattern, not altered growth per se, is the hallmark of early lesions preceding cancer development. Histol Histopathol. 2009, 24(1):101-106.
39. Doratiotto S., Krause P., Serra M.P., Marongiu F., Sini M., Koenig S., Laconi E. The growth pattern of transplanted normal and nodular hepatocytes. Histochem Cell Biol 2011, 135(6):581-591.
40. Draisma G. Lead times and overdetection due to prostatespecific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003, 95:868-878.
41. Ehrenstein M.R., Notley C.A. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 2010, 10(11):778-786.
42. Epstein E.H. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008, 8:743-754.
43. Epstein J.I. Precursor lesions to prostatic adenocarcinoma. Virchows Arch. 2009, 454(1):1-16.
44. Etienne-Manneville S., Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 2003, 421:753-756.
45. Fan H., Oro A.E., Scott M.P., Khavari P.A. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med. 1997, 3(7):788-792.
46. Fang J., Yan L., Shing Y., Moses M.A. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res. 2001, 61(15):5731-5735.
47. Farber E., Cameron R. The sequential analysis of cancer development. Adv Cancer Res. 1980, 31:125-226.
48. Fiaschi M., Rozell B., Bergström A., Toftgård R. Development of mammary tumors by conditional expression of GLI1. Cancer Res. 2009, 69(11):4810-4817.
49. Fiaschi M., Kolterud A., Nilsson M., Toftgård R., Rozell B. Targeted expression of GLI1 in the salivary glands results in an altered differentiation program and hyperplasia. Am J Pathol. 2011, 179(5):2569-2579.
50. Fleenor C.J., Marusyk A., DeGregori J. Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle 2010, 9(15):3005-3011.
51. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285(21):1182-1186.
52. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992, 3(2):65-71.
53. Foulds L. Neoplastic development 1969, Volume I. Academic Press, London.
54. Gardner L.B., Li Q., Park M.S., Flanagan W.M., Semenza G.L., Dang C.V. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 2001, 276:7919-7926.
55. Gebhardt R., Baldysiak-Figiel A., Krügel V., Ueberham E., Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 2007, 41(4):201-266.
56. Geboes K., Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000, 37(2):99-107.
57. Gillies R.J., Verduzco D., Gatenby R.A. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 2012, 12(7):487-493.
58. Gimbrone M.A., Leapman S.B., Cotran R.S., Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972, 136(2):261-276.
59. Goda N., Ryan H.E., Khadivi B., McNulty W., Rickert R.C., Johnson R.S. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003, 23:359-369.
60. González-Mariscal L., Lechuga S., Garay E. Role of tight junctions in cell proliferation and cancer. Prog Histochem Cytochem 2007, 42(1):1-57.
61. Goodrich L.V., Milenkovic L., Higgins K.M., Scott M.P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997, 277:1109-1113.
62. Gorlin R.J. Nevoid basal-cell carcinoma syndrome. Medicine 1987, 66:98-113.
63. Green J. Morphogen gradients, positional information, and Xenopus: interplay of theory and experiment. Dev Dyn 2002, 225(4):392-408.
64. Grzeschik N.A., Parsons L.M., Allott M.L., Harvey K.F., Richardson H.E. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 2010, 20(7):573-581.
65. Gullino P.M. Considerations on the preneoplastic lesions of the mammary gland. Am J Pathol 1977, 89(2):413-430.
66. Guo W., Pylayeva Y., Pepe A., Yoshioka T., Muller W.J., Inghirami G., Giancotti F.G. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006, 126(3):489-502.
67. Hahn H., Wicking C., Zaphiropoulos P.G., et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85(6):841-851.
68. Harach H.R., Franssila K.O., Wasenius V.M. Occult papillary carcinoma of the thyroid. A " normal" finding in Finland. A systematic autopsy study. Cancer 1985, 56:531-538.
69. Hooper J.E., Scott M.P. Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005, 6:306-317.
70. Huang L.E., Bindra R.S., Glazer P.M., Harris A.L. Hypoxia-induced genetic instability--a calculated mechanism underlying tumorprogression. J Mol Med (Berl) 2007, 85(2):139-148.
71. Huang S. Reprogramming cell fates: reconciling rarity with robustness. Bioessays 2009, 31:546-560.
72. Huang T., Civelek A.C., Li J., Jiang H., Ng C.K., Postel G.C., Shen B., Li X.F. Tumor Microenvironment-Dependent 18F-FDG, 18F-Fluorothymidine, and 18F-Misonidazole Uptake: A Pilot Study in Mouse Models of Human Non-Small Cell Lung Cancer. J Nucl Med 2012 Jun 19, (Epub).
73. Hytiroglou P., Park Y.N., Krinsky G., Theise N.D. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007, 36(4):867-887.
74. Incassati A., Chandramouli A., Eelkema R., Cowin P. Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res 2010, 12(6):213.
75. Jensen H.M., Wellings S.R. Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse. Cancer Res 1976, 36(7 pt 2):2605-2610.
76. Jiang J., Hui C.C. Hedgehog signalling in development and cancer. Dev Cell 2008, 15(6):801-812.
77. Kalager M., Adami H.O., Bretthauer M., Tamimi R.M. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012, 156(7):491-499.
78. Kaluz S., Kaluzová M., Liao S.Y., Lerman M., Stanbridge E.J. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?. Biochim Biophys Acta 2009, 1795(2):162-172.
79. Kapadia C.R. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol 2003, 36(5 Suppl):S29-S36. discussion S61-2.
80. Klezovitch O., Fernandez T.E., Tapscott S.J., Vasioukhin V. Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev 2004, 18(5):559-571.
81. Koga Y., Yao T., Hirahashi M., Kumashiro Y., Ohji Y., Yamada T., Tanaka M., Tsuneyoshi M. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence. Histopathology 2008, 52(5):569-577.
82. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., Huang L.E. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004, 23(9):1949-1956.
83. Kuehn E.W., Walz G., Benzing T. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res 2007, 67(10):4537-4540.
84. Kukitsu T., Takayama T., Miyanishi K., Nobuoka A., Katsuki S., Sato Y., Takimoto R., Matsunaga T., Kato J., Sonoda T., Sakamaki S., Niitsu Y. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res 2008, 14(1):48-54.
85. Kumareswaran R., Ludkovski O., Meng A., Sykes J., Pintilie M., Bristow R.G. Chronic hypoxia compromises repair of DNA double-strand breaks to drivegenetic instability. J Cell Sci 2012, 125(Pt 1):189-199.
86. Laconi E., Sarma D.S., Pani P. Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 1995, 16(1):139-142.
87. Laconi E., Oren R., Mukhopadhyay D.K., Hurston E., Laconi S., Pani P., Dabeva M.D., Shafritz D.A. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 1998, 153(1):319-329.
88. Laconi E. Differential growth: from carcinogenesis to liver repopulation. Am J Pathol 2000, 156(2):389-392.
89. Laconi E., Pani P., Farber E. The resistance phenotype in the development and treatment of cancer. Lancet Oncol 2000, 1:235-241.
90. Laconi E. The evolving concept of tumor microenvironments. Bioessays 2007, 29(8):738-744.
91. Laconi E., Doratiotto S., Vineis P. The microenvironments of multistage carcinogenesis. Semin Cancer Biol 2008, 18(5):322-329.
92. Laconi S., Pillai S., Porcu P.P., Shafritz D.A., Pani P., Laconi E. Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol. 2001, 158(2):771-777.
93. Laconi S., Pani P., Pillai S., Pasciu D., Sarma D.S., Laconi E. A growth-constrained environment drives tumor progression in vivo. Proc Natl Acad Sci USA 2001, 98(14):7806-7811.
94. Lamlum H., Papadopoulou A., Ilyas M., Rowan A., Gillet C., Hanby A., Talbot I., Bodmer W., Tomlinson I. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 2000, 97(5):2225-2228.
95. Lantuéjoul S., Salameire D., Salon C., Brambilla E. Pulmonary preneoplasia--sequential molecular carcinogenetic events. Histopathology 2009, 54(1):43-54.
96. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999, 274:7936-7940.
97. Lee R.G., Tsamandas A.C., Demetris A.J. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology 1997, 26(6):1415-1422.
98. Lee W.Y., Huang S.C., Hsu K.F., Tzeng C.C., Shen W.L. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecol Oncol 2008, 108(2):377-384.
99. Lee Y.H., Oh B.K., Yoo J.E., Yoon S.M., Choi J., Kim K.S., Park Y.N. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol 2009, 22(8):1121-1131.
100. Leontieva O.V., Gudkov A.V., Blagosklonny M.V. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010, 9:4323-4327.
101. Lewis M.T., Ross S., Strickland P.A., Sugnet C.W., Jimenez E., Scott M.P., Daniel C.W. Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development 1999, 126(22):5181-5193.
102. Li X.F., Carlin S., Urano M., Russell J., Ling C.C., O'Donoghue J.A. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res 2007, 67(16):7646-7653.
103. Linggi B., Carpenter G. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 2006, 16:649-656.
104. Litingtung Y., Lei L., Westphal H., Chiang C. Sonic hedgehog is essential to foregut development. Nat Genet 1998, 20(1):58-61.
105. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
106. Lou Y., McDonald P.C., Oloumi A., Chia S., Ostlund C., Ahmadi A., Kyle A., Auf dem Keller U., Leung S., Huntsman D., Clarke B., Sutherland B.W., Waterhouse D., Bally M., Roskelley C., Overall C.M., Minchinton A., Pacchiano F., Carta F., Scozzafava A., Touisni N., Winum J.Y., Supuran C.T., Dedhar S. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011, 71(9):3364-3376.
107. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009, 17(1):9-26.
108. Manser R.L., Dodd M., Byrnes G., Irving L.B., Campbell D.A. Incidental lung cancers identified at coronial autopsy: implications for overdiagnosis of lung cancer by screening. Respir Med 2005, 99:501-507.
109. Martin-Belmonte F., Mostov K. Regulation of cell polarity during epithelial morphogenesis. Curr Opin Cell Biol 2008, 20(2):227-234.
110. Martin-Belmonte F., Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2011, 12(1):23-38.
111. Marongiu F., Doratiotto S., Montisci S., Pani P., Laconi E. Liver repopulation and carcinogenesis: two sides of the same coin?. Am J Pathol 2008, 172(4):857-864.
112. Marusyk A., Casás-Selves M., Henry C.J., Zaberezhnyy V., Klawitter J., Christians U., DeGregori J. Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. Cancer Res 2009, 69(18):7262-7269.
113. Massimi P., Narayan N., Cuenda A., Banks L. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation. Oncogene 2006, 25:4276-4285.
114. McMahon A.P., Ingham P.W., Tabin C.J. Developmental roles and clinical significance of hedgehog signaling. Curr Top Dev Biol 2003, 53:1-114.
115. Mole D.R., Blancher C., Copley R.R., Pollard P.J., Gleadle J.M., Ragoussis J., Ratcliffe P.J. Genome-wide association of hypoxia-inducible factor (HIF)-1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 2009, 284:16767-16775.
116. Montironi R., Mazzucchelli R., Lopez-Beltran A., Scarpelli M., Cheng L. Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance. BJU Int 2011, 108(9):1394-1401.
117. Moraes R.C., Zhang X., Harrington N., Fung J.Y., Wu M.F., Hilsenbeck S.G., Allred D.C., Lewis M.T. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 2007, 134(6):1231-1242.
118. Morson B.C. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955, 9:377-385.
119. Morson B.C. Evolution of cancer of the colon and rectum. Cancer 1974, 34(3S):845-849.
120. Nahmad M., Lander A.D. Spatiotemporal mechanisms of morphogen gradient interpretation. Curr Opin Genet Dev 2011, 21(6):726-731.
121. Näthke I., Rocha S. Antagonistic crosstalk between APC and HIF-1α. Cell Cycle 2011, 10(10):1545-1547.
122. Nejak-Bowen K.N., Monga S.P. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 2011, 21(1):44-58.
123. Newton I.P., Kenneth N.S., Appleton P.L., Näthke I., Rocha S. Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. Mol Biol Cell 2010, 21(21):3630-3638.
124. Nielsen M., Thomsen J.L., Primdahl S., Dyreborg U., Andersen J.A. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987, 56:814-819.
125. Ollila S., Mäkelä T.P. The tumor suppressor kinase LKB1: lessons from mouse models. J Mol Cell Biol 2011, 3(6):330-340.
126. Omenetti A., Choi S., Michelotti G., Diehl A.M. Hedgehog signaling in the liver. J Hepatol. 2011, 54(2):366-373.
127. Oro A.E., Higgins K.M., Hu Z., Bonifas J.M., Epstein E.H., Scott M.P. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 1997, 276(5313):817-821.
128. Oshima H., Oshima M., Kobayashi M., Tsutsumi M., Taketo M.M. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice. Cancer Res 1997, 57(9):1644-1649.
129. Packer L., Fuehr K. Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature 1977, 267:423-425.
130. Page D.L., Dupont W.D., Rogers L.W., Rados M.S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985, 55(11):2698-2708.
131. Park Y.N., Roncalli M. Large liver cell dysplasia: a controversial entity. J Hepatol 2006, 45(5):734-743.
132. Park Y.N. Update on Precursor and Early Lesions of Hepatocellular Carcinomas. Arch Pathol Lab Med 2011, 135(6):704-715.
133. Pasciu D., Montisci S., Greco M., Doratiotto S., Pitzalis S., Pani P., Laconi S., Laconi E. Aging is associated with increased clonogenic potential in rat liver in vivo. Aging Cell 2006, 5(5):373-377.
134. Pearson H.B., Perez-Mancera P.A., Dow L.E., Ryan A., Tennstedt P., Bogani D., Elsum I., Greenfield A., Tuveson D.A., Simon R., Humbert P.O. SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. J Clin Invest 2011, 121(11):4257-4267.
135. Pires I.M., Bencokova Z., Milani M., Folkes L.K., Li J.L., Stratford M.R., Harris A.L., Hammond E.M. Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. Cancer Res 2010, 70(3):925-935.
136. Porter J.A., Young K.E., Beachy P.A. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996, 274:255-259.
137. Potter J.D. Morphostats: a missing concept in cancer biology. Cancer Epidemiol Biomarkers Prev 2001, 10(3):161-170.
138. Potter J.D. Morphogens, morphostats, microarchitecture and malignancy. Nat Rev Cancer 2007, 7:464-474.
139. Prasad N.B., Biankin A.V., Fukushima N., Maitra A., Dhara S., Elkahloun A.G., Hruban R.H., Goggins M., Leach S.D. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005, 65(5):1619-1626.
140. Preston S.L., Wong W.M., Chan A.O., Poulsom R., Jeffery R., Goodlad R.A., Mandir N., Elia G., Novelli M., Bodmer W.F., Tomlinson I.P., Wright N.A. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003, 63(13):3819-3825.
141. Preston S.L., Leedham S.J., Oukrif D., Deheregoda M., Goodlad R.A., Poulsom R., Alison M.R., Wright N.A., Novelli M .The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse. J Pathol 2008, 214(3):294-301.
142. Pretlow T.P., Barrow B.J., Ashton W.S., O'Riordan M.A., Pretlow T.G., Jurcisek J.A., Stellato T.A. Aberrant crypts: putative preneoplastic foci in humancolonic mucosa. Cancer Res 1991, 51:1564-1567.
143. Prosperi J.R., Becher K.R., Willson T.A., Collins M.H., Witte D.P., Goss K.H. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland. J Cell Physiol 2009, 220(2):319-331.
144. Quaranta V., Rejniak K.A., Gerlee P., Anderson A.R. Invasion emerges from cancer cell adaptation to competitive microenvironments: quantitative predictions from multiscale mathematical models. Semin Cancer Biol 2008, 18(5):338-348.
145. Ratcliffe P.J. New insights into an enigmatic tumour suppressor. Nat Cell Biol 2003, 5(1):7-8.
146. Reynolds T.Y., Rockwell S., Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res 1996, 56:5754-5757.
147. Rich A.R. On the frequency of occurrence of occult carcinoma of the prostate. Journal of Urology 1935, 33:215-223. (Reprinted Int J Epidemiol. 2007;36:274-77).
148. Risio M. The natural history of adenomas. Best Pract Res Clin Gastroenterol 2010, 24(3):271-280.
149. Rohatgi R., Milenkovic L., Scott M.P. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007, 317:372-376.
150. Roncalli M., Borzio M., Brando B., Colloredo G., Servida E. Abnormal DNA content in liver-cell dysplasia: a flow cytometric study. Int J Cancer 1989, 44(2):204-207.
151. Rooman I., Real F.X. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?. Gut 2012, 61(3):449-458.
152. Saab R. Senescence and pre-malignancy: how do tumors progress?. Semin Cancer Biol. 2011 Dec, 21(6):385-391.
153. Salazar H., Godwin A.K., Daly M.B., Laub P.B., Hogan W.M., Rosenblum N., Boente M.P., Lynch H.T., Hamilton T.C. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst 1996, 88(24):1810-1820.
154. Schlemper R.J., Riddell R.H., Kato Y., Borchard F., Cooper H.S., Dawsey S.M., Dixon M.F., Fenoglio-Preiser C.M., Fléjou J.F., Geboes K., Hattori T., Hirota T., Itabashi M., Iwafuchi M., Iwashita A., Kim Y.I., Kirchner T., Klimpfinger M., Koike M., Lauwers G.Y., Lewin K.J., Oberhuber G., Offner F., Price A.B., Rubio C.A., Shimizu M., Shimoda T., Sipponen P., Solcia E., Stolte M., Watanabe H., Yamabe H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47(2):251-255.
155. Schroeder M.C., Halder G. Regulation of the Hippo pathway by cell architecture and mechanical signals. Semin Cell Dev Biol 2012 Jun 26, (Epub).
156. Semenza G.L. HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 2000, 19(1-2):59-65.
157. Semenza G.L. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010, 20(1):51-56.
158. Serra M.P., Marongiu F., Sini M., Laconi E. Hepatocyte senescence in vivo following preconditioning for liver repopulation. Hepatology 2012 Mar 5, (Epub).
159. Silva A.S., Yunes J.A., Gillies R.J., Gatenby RA The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res 2009, 69(6):2677-2684.
160. Silva A.S., Gatenby R.A. Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma. Mol Pharm 2011, 8(6):2012-2020.
161. Solt D., Farber E. New principle for the analysis of chemical carcinogenesis. Nature (Lond.) 1976, 263:702-703.
162. Song M.S., Salmena L., Pandolfi P.P. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012, 13(5):283-296.
163. Sonnenschein C., Soto A.M. The Society of Cells: Cancer and control of cell proliferation 1999, Springer-Verlag, New York.
164. Spechler S.J., Goyal R.K. Barrett's esophagus. N Engl J Med 1986, 315:362-371.
165. Sprent J., Cho J.H. Self/non-self discrimination and the problem of keeping T cells alive. Immunol Cell Biol 2008, 86(1):54-56.
166. St.Johnston D., Ahringer J. Cell polarity in eggs and epithelia: parallels and diversity. Cell 2010, 141:757-774.
167. Stein T.J., Jochem A., Holmes K.E., Sandgren E.P. Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice. Liver Int 2011, 31(3):303-312.
168. Steinhagen E., Guillem J.G., Chang G., Salo-Mullen E.E., Shia J., Fish S., Stadler Z.K., Markowitz A.J. The Prevalence of Thyroid Cancer and Benign Thyroid Disease in Patients With Familial adenomatous Polyposis May Be Higher Than Previously Recognized. Clin Colorectal Cancer 2012 Mar 14, Epub.
169. Stewart S.L., Querec T.D., Ochman A.R., Gruver B.N., Bao R., Babb J.S., Wong T.S., Koutroukides T., Pinnola A.D., Klein-Szanto A., Hamilton T.C., Patriotis C. Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res 2004, 64(22):8177-8183.
170. Stoll M., Corneliussen B., Costello C.M., Waetzig G.H., Mellgard B., Koch W.A., Rosenstiel P., Albrecht M., Croucher P.J., Seegert D., Nikolaus S., Hampe J., Lengauer T., Pierrou S., Foelsch U.R., Mathew C.G., Lagerstrom-Fermer M., Schreiber S. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nature Genet 2004, 36:476-480.
171. Summerhayes I.C., Bradley N.J., Joyce A.D., Malone P.M. Transplantation of immortalized bladder epithelial cell lines in denuded mouse bladder. J Urol 1988, 139(2):405-409.
172. Sun Q., Tsutsumi K., Kelleher M.B., Pater A., Pater M.M. Squamous metaplasia of normal and carcinoma in situ of HPV 16-immortalized human endocervical cells. Cancer Res 1992, 52(15):4254-4260.
173. Suzuki A., Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci 2006, 119:979-987.
174. Takaori K., Hruban R.H., Maitra A., Tanigawa N. Pancreatic intraepithelial neoplasia. Pancreas 2004, 28(3):257-262.
175. Terris B., Ingster O., Rubbia L., Dubois S., Belghiti J., Feldmann G., Degott C., Hénin D. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol 1997, 27(2):313-331.
176. Terzaghi M., Nettesheim P., Williams M.L. Repopulation of denuded tracheal grafts with normal, preneoplastic, and neoplastic epithelial cell populations. Cancer Res 1978, 38:4546-4553.
177. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernández-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425(6960):851-856.
178. Thomas R.M., Berman J.J., Yetter R.A., Moore G.W., Hutchins G.M. Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features. Hum Pathol 1992, 23(5):496-503.
179. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level 1 ≤4.0ng per milliliter. N Engl J Med 2004, 350:2239-2246.
180. Tumaneng K., Russell R.C., Guan K.L. Organ Size Control by Hippo and TOR Pathways. Curr Biol 2012, 22(9):R368-R379.
181. van Hengel J., D'Hooge P., Hooghe B., Wu X., Libbrecht L., De Vos R., Quondamatteo F., Klempt M., Brakebusch C., van Roy F. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. Gastroenterology 2008, 134(3):781-792.
182. Varjosalo M., Li S.P., Taipale J. Divergence of hedgehog signal transduction mechanism between Drosophila and mammals. Dev Cell 2006, 10:177-186.
183. Vaupel P. Metabolic microenvironment of tumor cells: a key factor in malignant progression. Exp Oncol 2010, 32(3):125-127.
184. Walch A.K., Zitzelsberger H.F., Bruch J., Keller G., Angermeier D., Aubele M.M., Mueller J., Stein H., Braselmann H., Siewert J.R., Höfler H., Werner M. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol 2000, 156(2):555-566.
185. Wang D., Pezo R.C., Corner G., Sison C., Lesser M.L., Shenoy S.M., Mariadason J.M., Singer R.H., Augenlicht L.H. Altered dynamics of intestinal cell maturation in Apc1638N/+ mice. Cancer Res 2010, 70(13):5348-5357.
186. Wang D.H., Clemons N.J., Miyashita T., Dupuy A.J., Zhang W., Szczepny A., Corcoran-Schwartz I.M., Wilburn D.L., Montgomery E.A., Wang J.S., Jenkins N.A., Copeland N.A., Harmon J.W., Phillips W.A., Watkins D.N. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010, 138(5):1810-1822.
187. Wang F., Weaver V.M., Petersen O.W., Larabell C.A., Dedhar S., Briand P., Lupu R., Bissell M.J. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 1998, 95(25):14821-14826.
188. Wang W., Bergh A., Damber J.E. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009, 69(13):1378-1386.
189. Welford S.M., Giaccia A.J. Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol Cancer Res 2011, 9(5):538-544.
190. White B.D., Chien A.J., Dawson D.W. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 2012, 142(2):219-232.
191. Wodarz A., Nathke I. Cell polarity in development and cancer. Nat Cell Biol 2007, 9(9):1016-1024.
192. World Health Organization. Histological Typing of Lung Tumours. International classification of Tumours. 1981. No 1. Geneva.
193. Zhan L., Rosenberg A., Bergami K.C., Yu M., Xuan Z., Jaffe A.B., Allred C., Muthuswamy S.K. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008, 135(5):865-878.